Held on 04 January 2017
Bafna Pharmaceuticals announced that the Board of Directors of the company at its meeting held on 04 January 2017 has considered and approved the withdrawal of entire preferential issue of 40 lakh share warrants and in-principle application filed with the stock exchange.The Board has decided to call a separate meeting of the Board of Directors on 07 January 2017 to consider and propose fresh issue of 80 lakh share warrants and/or explore various other options for raising funds.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
